ACCESSIBILITY

24/7

Headlines

18:06

Who pays when an AI agent tries again?

13:00

Brandlight helps enterprise marketers manage how AI recommends their brand

12:00

BlueGreen Water Technologies turns algae blooms into large-scale carbon removal

11:21

Taboola to acquire Dianomi for up to £27 million as it pushes deeper into finance advertising

Buzz

Most popular

Daily

Weekly

Serbia opens Israeli drone factory as defense ties with Elbit deepen

The man who helped build Palo Alto’s Cortex is leaving the company

“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B

How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit

Sayeret Matkal veterans raise $22 million to teach the world English with AI

More news

Biomed

10 stories about Biomed

Three Portfolio Companies of Len Blavatnik's Clal Biotechnology Raise Cash in One Week

04.07.18|CTech

Clal Biotechnology Industries is an Israel-based life sciences investment company

Fourth Time’s the Charm for Entera Bio IPO

01.07.18|Dror Reich

The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each

Entera Bio Gives Nasdaq IPO Another Shot

21.05.18|Dror Reich

This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq

Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange

29.04.18|Racheli Bindman

Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April

An Israeli Company Wants to Treat Tourette Syndrome With Cannabis

09.04.18|Lilach Baumer

Therapix Biosciences announced the successful completion of phase 2 clinical trial of its cannabinoid-based drug, conducted at Yale University Monday

For the Fourth Time, Entera Bio Tries for Nasdaq IPO

08.01.18|Dror Reich

The Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter

Biomed Company Protalix to Lay Off a Fifth of its Workforce

26.11.17|Dror Reich

The Israel-based NYSE American-listed company is currently undergoing a streamlining process

Entera Bio Files for Nasdaq IPO

12.11.17|Lilach Baumer

The clinical stage company develops treatments mostly for osteoporosis and bone disorders

Collplant Takes a Step Towards 3D Organ Printing

17.10.17|Lilach Baumer

The Israel-based company develops collagen-based biological ink for 3D organ printing

IPO Hopeful Entera Bio Moves to Better Position

13.09.17|Dror Reich

Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism